The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Herpes zoster, from the experts the point on vaccination in Tuscany Jul 16, 2021
- Stepanov told how fine the Ukrainians for no mask Jul 2, 2020
- New York launches cyber defense center in the heart of Manhattan Jul 9, 2021
- Belen Rodriguez in the storm: special treatment at the hospital? Jul 15, 2021
- The experience of being a teacher and mother in the midst of the pandemic | Video May 29, 2021
- Convicted of setting up 21 fake pharmacies in Miami and defrauding 9 million Jun 4, 2022
- Covid vaccine at 12-15 year olds, Pregliasco to parents: “It must be done” Sep 4, 2021